Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Viral Inactivation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Inactivation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Inactivation Overall Market Size
2.1 Global Viral Inactivation Market Size: 2021 VS 2028
2.2 Global Viral Inactivation Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Inactivation Players in Global Market
3.2 Top Global Viral Inactivation Companies Ranked by Revenue
3.3 Global Viral Inactivation Revenue by Companies
3.4 Top 3 and Top 5 Viral Inactivation Companies in Global Market, by Revenue in 2021
3.5 Global Companies Viral Inactivation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Inactivation Players in Global Market
3.6.1 List of Global Tier 1 Viral Inactivation Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Inactivation Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Viral Inactivation Market Size Markets, 2021 & 2028
4.1.2 Kits and Reagents
4.1.3 Services
4.1.4 Viral Inactivation Systems and Accessories
4.2 By Type - Global Viral Inactivation Revenue & Forecasts
4.2.1 By Type - Global Viral Inactivation Revenue, 2017-2022
4.2.2 By Type - Global Viral Inactivation Revenue, 2023-2028
4.2.3 By Type - Global Viral Inactivation Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Inactivation Market Size, 2021 & 2028
5.1.2 Blood and Blood Products
5.1.3 Cellular and Gene Therapy Products
5.1.4 Stem Cell Products
5.1.5 Tissue and Tissue Products
5.1.6 Vaccines and Therapeutics
5.2 By Application - Global Viral Inactivation Revenue & Forecasts
5.2.1 By Application - Global Viral Inactivation Revenue, 2017-2022
5.2.2 By Application - Global Viral Inactivation Revenue, 2023-2028
5.2.3 By Application - Global Viral Inactivation Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Viral Inactivation Market Size, 2021 & 2028
6.2 By Region - Global Viral Inactivation Revenue & Forecasts
6.2.1 By Region - Global Viral Inactivation Revenue, 2017-2022
6.2.2 By Region - Global Viral Inactivation Revenue, 2023-2028
6.2.3 By Region - Global Viral Inactivation Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Viral Inactivation Revenue, 2017-2028
6.3.2 US Viral Inactivation Market Size, 2017-2028
6.3.3 Canada Viral Inactivation Market Size, 2017-2028
6.3.4 Mexico Viral Inactivation Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Viral Inactivation Revenue, 2017-2028
6.4.2 Germany Viral Inactivation Market Size, 2017-2028
6.4.3 France Viral Inactivation Market Size, 2017-2028
6.4.4 U.K. Viral Inactivation Market Size, 2017-2028
6.4.5 Italy Viral Inactivation Market Size, 2017-2028
6.4.6 Russia Viral Inactivation Market Size, 2017-2028
6.4.7 Nordic Countries Viral Inactivation Market Size, 2017-2028
6.4.8 Benelux Viral Inactivation Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Viral Inactivation Revenue, 2017-2028
6.5.2 China Viral Inactivation Market Size, 2017-2028
6.5.3 Japan Viral Inactivation Market Size, 2017-2028
6.5.4 South Korea Viral Inactivation Market Size, 2017-2028
6.5.5 Southeast Asia Viral Inactivation Market Size, 2017-2028
6.5.6 India Viral Inactivation Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Viral Inactivation Revenue, 2017-2028
6.6.2 Brazil Viral Inactivation Market Size, 2017-2028
6.6.3 Argentina Viral Inactivation Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Inactivation Revenue, 2017-2028
6.7.2 Turkey Viral Inactivation Market Size, 2017-2028
6.7.3 Israel Viral Inactivation Market Size, 2017-2028
6.7.4 Saudi Arabia Viral Inactivation Market Size, 2017-2028
6.7.5 UAE Viral Inactivation Market Size, 2017-2028
7 Players Profiles
7.1 Danaher
7.1.1 Danaher Corporate Summary
7.1.2 Danaher Business Overview
7.1.3 Danaher Viral Inactivation Major Product Offerings
7.1.4 Danaher Viral Inactivation Revenue in Global Market (2017-2022)
7.1.5 Danaher Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Viral Inactivation Major Product Offerings
7.2.4 Merck Viral Inactivation Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Parker Hannifin
7.3.1 Parker Hannifin Corporate Summary
7.3.2 Parker Hannifin Business Overview
7.3.3 Parker Hannifin Viral Inactivation Major Product Offerings
7.3.4 Parker Hannifin Viral Inactivation Revenue in Global Market (2017-2022)
7.3.5 Parker Hannifin Key News
7.4 Sartorius
7.4.1 Sartorius Corporate Summary
7.4.2 Sartorius Business Overview
7.4.3 Sartorius Viral Inactivation Major Product Offerings
7.4.4 Sartorius Viral Inactivation Revenue in Global Market (2017-2022)
7.4.5 Sartorius Key News
7.5 SGS
7.5.1 SGS Corporate Summary
7.5.2 SGS Business Overview
7.5.3 SGS Viral Inactivation Major Product Offerings
7.5.4 SGS Viral Inactivation Revenue in Global Market (2017-2022)
7.5.5 SGS Key News
7.6 Charles River Laboratories International
7.6.1 Charles River Laboratories International Corporate Summary
7.6.2 Charles River Laboratories International Business Overview
7.6.3 Charles River Laboratories International Viral Inactivation Major Product Offerings
7.6.4 Charles River Laboratories International Viral Inactivation Revenue in Global Market (2017-2022)
7.6.5 Charles River Laboratories International Key News
7.7 Clean Cells
7.7.1 Clean Cells Corporate Summary
7.7.2 Clean Cells Business Overview
7.7.3 Clean Cells Viral Inactivation Major Product Offerings
7.7.4 Clean Cells Viral Inactivation Revenue in Global Market (2017-2022)
7.7.5 Clean Cells Key News
7.8 Rad Source Technologies
7.8.1 Rad Source Technologies Corporate Summary
7.8.2 Rad Source Technologies Business Overview
7.8.3 Rad Source Technologies Viral Inactivation Major Product Offerings
7.8.4 Rad Source Technologies Viral Inactivation Revenue in Global Market (2017-2022)
7.8.5 Rad Source Technologies Key News
7.9 Texcell
7.9.1 Texcell Corporate Summary
7.9.2 Texcell Business Overview
7.9.3 Texcell Viral Inactivation Major Product Offerings
7.9.4 Texcell Viral Inactivation Revenue in Global Market (2017-2022)
7.9.5 Texcell Key News
7.10 Viral Inactivated Plasma Systems
7.10.1 Viral Inactivated Plasma Systems Corporate Summary
7.10.2 Viral Inactivated Plasma Systems Business Overview
7.10.3 Viral Inactivated Plasma Systems Viral Inactivation Major Product Offerings
7.10.4 Viral Inactivated Plasma Systems Viral Inactivation Revenue in Global Market (2017-2022)
7.10.5 Viral Inactivated Plasma Systems Key News
7.11 Wuxi Pharmatech (Cayman)
7.11.1 Wuxi Pharmatech (Cayman) Corporate Summary
7.11.2 Wuxi Pharmatech (Cayman) Business Overview
7.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Major Product Offerings
7.11.4 Wuxi Pharmatech (Cayman) Viral Inactivation Revenue in Global Market (2017-2022)
7.11.5 Wuxi Pharmatech (Cayman) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer